Erratum to: 24-h Efficacy of Glaucoma Treatment Options

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Erratum to: 24-h Efficacy of Glaucoma Treatment Options

The family name of one of the co-authors, Julian Garcia-Feijoo, was incorrect in the original publication. The correct family name should be Garcia-Feijoo. The original article has been updated accordingly. Open Access. This article is distributed under the terms of the Creative Commons AttributionNonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4. 0/), which p...

متن کامل

24-h Efficacy of Glaucoma Treatment Options

Current management of glaucoma entails the medical, laser, or surgical reduction of intraocular pressure (IOP) to a predetermined level of target IOP, which is commensurate with either stability or delayed progression of visual loss. In the published literature, the hypothesis is often made that IOP control implies a single IOP measurement over time. Although the follow-up of glaucoma patients ...

متن کامل

Current Options for Surgical Treatment of Glaucoma.

The purpose of this study is to review current surgical treatment and new and better alternatives for patients with glaucoma. Glaucoma refers to a group of related eye disorders that have in common an optic neuropathy associated with visual function loss. It is one of the leading causes of irreversible blindness worldwide. Optic nerve damage and glaucoma-related vision loss can be prevented or ...

متن کامل

Erratum: Treatment options for pediatric craniopharyngioma

[This corrects the article on p. S174 in vol. 7, PMID: 27057397.].

متن کامل

Erratum to: Chordoma: The Quest for Better Treatment Options

The author of the above mentioned paper have noticed a mistake in Table 1 following publication and wish to make the following correction. The reference for the lapatinib study should be 36 (Stacchiotti S, Tamborini E, Lo Vullo S, et al. Phase II study on lapatinib in advanced EGFR-positive chordoma. Ann Oncol. 2013;24:1931–6), and the reference for the 9-nitro-camptothecin study should be 43 (...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Advances in Therapy

سال: 2016

ISSN: 0741-238X,1865-8652

DOI: 10.1007/s12325-016-0316-7